Loading...
 
Toggle Health Problems and D

Depression would be cost-effectively decreased in teens by Vitamin D (Iran) – July 2023


Is vitamin D supplementation program in Iranian schools effective in reducing adolescent depressive symptoms? Cost effectiveness study

BMC Public Health . 2023 Jul 20;23(1):1393. doi: 10.1186/s12889-023-16244-z. PDF behind paywall
Seyed Vahid Jasemi 1, Zhale Zandieh 2, Narges Zandieh 1, Mohsen Rezaei Hemami 3, Ali Darvishi 4 5, Zahra Abdollahi 6, Ramin Heshmat 7

Purpose: We aimed to assess the cost-effectiveness of the vitamin D supplementation program in Iranian adolescents reducing adolescent depressive Symptoms.

Methods: In the current cost-effectiveness analysis, the viewpoint of Iran's Ministry of Health was selected. The target population was 1,519,762 Iranian high school students (733,657 girls and 786,105 boys). The total costs of the vitamin D supplementations program were based on the reports of the Nutrition Improvement Office of Iran's Ministry of Health and were adjusted to 2018. The variable of Quality-Adjusted Life Years (QALYs) was considered a suitable variable for estimating the effectiveness of vitamin D supplementation. We chose one year as the time horizon. A decision tree model was constructed in TreeAge Pro. The results of the cost-effectiveness analysis were reported in term of the Incremental Cost-Effectiveness Ratio (ICER).

Results: The results of our study showed that the estimated cost per QALY gained of the vitamin D supplementation program is equal to 1528.6676 $, which indicates that vitamin D supplementation in adolescents(11-18Y) is a cost-effective and a dominant strategy in preventing depression through the cost-saving and QALYs increment compared to the no intervention. Sensitivity analysis showed that the possible variations in vitamin D supplement costs could not alter the results, and vitamin D supplementation may be a predominant and cost-effective strategy to prevent adulthood depression with a 100% probability.

Conclusion: The national program of vitamin D supplementation among Iranian adolescents was a cost-efficient strategy reducing adolescent depressive Symptoms through the cost-saving and QALYs increment compared to the no intervention.

38 References
  1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (London, England). 2006;367(9524):1747–57. - DOI - PubMed
  2. Ustün TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004;184:386–92. - DOI - PubMed
  3. Reddy MS. Depression: the disorder and the burden. Indian J Psychol Med. 2010;32(1):1–2. - DOI - PubMed - PMC
  4. WHO. The global burden of disease: 2004 update. World Health Organization; 2008. https://apps.who.int/iris/handle/10665/43942 .
  5. WHO. Depression. 2020. https://www.whoint/news-room/fact-sheets/detail/depression . Accessed 2 May 2021.
  6. Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119–38. - DOI - PubMed - PMC
  7. Milaneschi Y, Hoogendijk W, Lips P, Heijboer AC, Schoevers R, van Hemert AM, et al. The association between low vitamin D and depressive disorders. Mol Psychiatry. 2014;19(4):444–51. - DOI - PubMed
  8. Vellekkatt F, Menon V. Efficacy of vitamin D supplementation in major depression: a meta-analysis of randomized controlled trials. J Postgrad Med. 2019;65(2):74–80. - PubMed - PMC
  9. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21–30. - DOI - PubMed
  10. Fernandes de Abreu DA, Eyles D, Eyles D, Féron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology. 2009;34(1):S265-77. - DOI - PubMed
  11. Geng C, Shaikh AS, Han W, Chen D, Guo Y, Jiang P. Vitamin D and depression: mechanisms, determination and application. Asia Pac J Clin Nutr. 2019;28(4):689–94. - PubMed
  12. Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013;202:100–7. - DOI - PubMed
  13. Armstrong DJ, Meenagh GK, Bickle I, Lee AS, Curran ES, Finch MB. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol. 2007;26(4):551–4. - DOI - PubMed
  14. Libuda L, Timmesfeld N, Antel J, Hirtz R, Bauer J, Führer D, et al. Effect of vitamin D deficiency on depressive symptoms in child and adolescent psychiatric patients: results of a randomized controlled trial. Eur J Nutr. 2020;59(8):3415–24. - DOI - PubMed - PMC
  15. Bahrami A, Mazloum SR, Maghsoudi S, Soleimani D, Khayyatzadeh SS, Arekhi S, et al. High dose vitamin D supplementation is associated with a reduction in depression score among adolescent girls: a nine-week follow-up study. J Dietary Suppl. 2018;15(2):173–82. - DOI
  16. Tartagni M, Cicinelli MV, Tartagni MV, Alrasheed H, Matteo M, Baldini D, et al. Vitamin D supplementation for premenstrual syndrome-related mood disorders in adolescents with severe hypovitaminosis D. J Pediatr Adolesc Gynecol. 2016;29(4):357–61. - DOI - PubMed
  17. Tabrizi R, Moosazadeh M, Akbari M, Dabbaghmanesh MH, Mohamadkhani M, Asemi Z, et al. High prevalence of vitamin D deficiency among Iranian population: a systematic review and meta-analysis. Iran J Med Sci. 2018;43(2):125–39. - PubMed - PMC
  18. Heshmat R, Mohammad K, Majdzadeh S, Forouzanfar M, Bahrami A, Ranjbar Omrani G, et al. Vitamin D deficiency in Iran: A multi-center study among different urban areas. Iran J Public Health. 2008;37(1):72–8.
  19. Ataie-Jafari A, Qorbani M, Heshmat R, Ardalan G, Motlagh ME, Asayesh H, et al. The association of vitamin D deficiency with psychiatric distress and violence behaviors in Iranian adolescents: the CASPIAN-III study. J Diabetes Metab Disord. 2015;14:62. - DOI - PubMed - PMC
  20. Husmann C, Frank M, Schmidt B, Jöckel KH, Antel J, et al. Low 25(OH)-vitamin D concentrations are associated with emotional and behavioral problems in German children and adolescents. PLoS One. 2017;12(8):83091. - DOI
  21. Robinson SL, Marín C, Oliveros H, Mora-Plazas M, Lozoff B, Villamor E. Vitamin D deficiency in middle childhood is related to behavior problems in adolescence. J Nutr. 2020;150(1):140–8. - DOI - PubMed
  22. Ssegonja R, Sampaio F, Alaie I, Philipson A, Hagberg L, Murray K, et al. Cost-effectiveness of an indicated preventive intervention for depression in adolescents: a model to support decision making. J Affect Disord. 2020;277:789–99. - DOI - PubMed
  23. Kolovos S, Bosmans JE, van Dongen JM, van Esveld B, Magai D, van Straten A, et al. Utility scores for different health states related to depression: individual participant data analysis. Qual Life Res. 2017;26(7):1649–58. - DOI - PubMed - PMC
  24. Goudarzi R, Zeraati H, Akbari Sari A, Rashidian A, Mohammad K. Population-based preference weights for the EQ-5D health states using the Visual Analogue Scale (VAS) in Iran. Iran Red Crescent Med J. 2016;18(2): e21584. - DOI - PubMed - PMC
  25. Goudarzi R, Sari AA, Zeraati H, Rashidian A, Mohammad K, Amini S. Valuation of quality weights for EuroQol 5-dimensional health states with the time trade-off method in the capital of Iran. Value Health Reg Issues. 2019;18:170–5. - DOI - PubMed
  26. Kelishadi R, Majdzadeh R, Motlagh ME, Heshmat R, Aminaee T, Ardalan G, et al. Development and evaluation of a questionnaire for assessment of determinants of weight disorders among children and adolescents: the Caspian-IV study. Int J Prev Med. 2012;3(10):699–705. - PubMed - PMC
  27. CBotIRo I. Central Bank of the Islamic Republic of Iran. 2018. https://www.cbiir/Inflation/Inflation_enaspx .
  28. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
  29. Weinstein MC, Torrance G, McGuire A. QALYs: the basics. Value Health. 2009;12(Suppl 1):S5-9. - DOI - PubMed
  30. Moradi N, Rashidian A, Nosratnejad S, Olyaeemanesh A, Zanganeh M, Zarei L. Willingness to pay for one quality-adjusted life year in Iran. Cost Eff Resour Alloc. 2019;17:4. - DOI - PubMed - PMC
  31. Rascati KL. Essentianls of pharmacoeconomics. 2009.
  32. Rafraf M, Hasanabad SK, Jafarabadi MA. Vitamin D status and its relationship with metabolic syndrome risk factors among adolescent girls in Boukan Iran. Public Health Nutr. 2014;17(4):803–9. - DOI - PubMed
  33. Kelishadi R, Qorbani M, Motlagh ME, Heshmat R, Poursafa P, Bahreynian M. Prevalence of vitamin D deficiency according to climate conditions among a nationally representative sample of Iranian adolescents: the CASPIAN-III study. Int J Pediatr. 2016;4(6):1903–10.
  34. Ghazizadeha A. Cost-Benefit Analysis of Treatment of Depressed Patients in Health System of Kurdistan Province in 1993. Sci J Kurdistan Univ Med Sci. 2001;5(3):14.
  35. Goudarzi R, Zeraati H, Sari AA, Rashidian A, Mohammad K. Population-based preference weights for the EQ-5D health states using the visual analogue scale (VAS) in Iran. Iran Red Crescent Med J. 2016;18(2):e21584. - DOI - PubMed - PMC
  36. Kuchay MS, Jevalikar GS, Mithal A, Mishra SK, Dang N. Efficacy and safety of a single monthly dose of cholecalciferol in healthy school children. J Pediatr Endocrinol Metab. 2016;29(4):413–6. - DOI - PubMed
  37. Ataie-Jafari A, Qorbani M, Heshmat R, Ardalan G, Motlagh ME, Asayesh H, et al. The association of vitamin D deficiency with psychiatric distress and violence behaviors in Iranian adolescents: the CASPIAN-III study. J Diabetes Metab Disord. 2015;14(1):1–11. - DOI
  38. Ghazizadeh A. Cost-benefit analysis of treatment of depressed patients in health system of Kurdistan province in 1993. 2001.

20+ VitaminDWiki pages have COST-EFFECTIVE in the title

This list is automatically updated

Items found: 21
Title Modified
96% prediction of Vitamin D less than 20ng (not general nor cost-effective) - May 2024 27 May, 2024
Depression would be cost-effectively decreased in teens by Vitamin D (Iran) – July 2023 21 Jul, 2023
Cost Effectivity of Vitamin D - old 21 Jul, 2023
Vitamin D has been found to be cost-effective by many studies 21 Jul, 2023
Cost-effective to give Vitamin D to all children to prevent acute respiratory infection – April 2023 09 Apr, 2023
Vitamin D Call for Action: at least 1,000 IU (free is cost-effective) - Oct 2022 04 Oct, 2022
Mild to moderate persistent asthma cost-effectively treated by Vitamin D – Aug 2022 03 Aug, 2022
Vitamin D cost-effectively treats Multiple Sclerosis – July 2021 28 Jun, 2022
Dutch Vitamin D cost-effectivity Calculations (they prescribe 100,000 IU for Multiple Sclerosis) – Jan 2022 28 Jun, 2022
Treating pre-diabetes with Magnesium Chloride should be cost effective – June 2022 05 Jun, 2022
Remdesivir approved to treat COVID in Infants, yet Vitamin D is 3000 X more cost effective and widely used - April 2022 03 May, 2022
Calcifediol (Calcidiol) is far less cost-effective and available than Vitamin D – RCT June 2021 04 Sep, 2021
Very cost-effective to fortify plus supplement with Vitamin D (flour and 400 IU for all children) – Aug 2019 20 Aug, 2019
Vitamin D and Calcium cost-effectively reduce falls and fractures – April 2019 02 May, 2019
Osteoporosis treatment – Vitamin D is the most cost-effective – April 2019 21 Apr, 2019
Give Vitamin D to all fracture patients – cost effective to prevent nonunions – Aug 2016 23 Oct, 2017
800 IU of vitamin D does not prevent enough falls to be cost effective - July 2015 29 Oct, 2016
Vitamin D supplementation of all pregnant women (in UK) would be cost effective – just considering preeclampsia – March 2016 09 Jul, 2016
Zika cost-effectiveness calculator - May 2016 05 Jun, 2016
Omega-3 should be cost-effective to reduce days in ICU – simulation June 2015 07 Jul, 2015
Vitamin D provides many benefits and is cost-effective (need 32-40 ng) – Summer 2013 15 Oct, 2013